NASDAQ:BCLI
$1.55
(
-2.21%
)
Friday, 24th Mar 2023
Brainstorm Cell Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.43 | $2.41 | Friday, 24th Mar 2023 BCLI stock ended at $1.55. This is 2.21% less than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 5.96% from a day low at $1.51 to a day high of $1.60. |
| 90 days | $1.35 | $3.00 | |
| 52 weeks | $1.09 | $4.70 |
Historical Brainstorm Cell Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2022-03-25 | $3.48 | $3.48 | $3.36 | $3.38 | 36 500 |
| 2022-03-24 | $3.46 | $3.49 | $3.41 | $3.47 | 27 000 |
| 2022-03-23 | $3.31 | $3.47 | $3.31 | $3.45 | 47 500 |
| 2022-03-22 | $3.40 | $3.44 | $3.28 | $3.35 | 73 298 |
| 2022-03-21 | $3.40 | $3.45 | $3.27 | $3.40 | 40 240 |
| 2022-03-18 | $3.34 | $3.38 | $3.25 | $3.38 | 100 709 |
| 2022-03-17 | $3.21 | $3.34 | $3.20 | $3.34 | 56 500 |
| 2022-03-16 | $3.18 | $3.26 | $3.15 | $3.25 | 68 700 |
| 2022-03-15 | $3.06 | $3.22 | $3.05 | $3.15 | 74 700 |
| 2022-03-14 | $3.01 | $3.13 | $3.01 | $3.09 | 60 100 |
| 2022-03-11 | $3.11 | $3.14 | $3.04 | $3.10 | 39 000 |
| 2022-03-10 | $3.11 | $3.15 | $3.06 | $3.11 | 41 300 |
| 2022-03-09 | $3.00 | $3.17 | $3.00 | $3.13 | 55 100 |
| 2022-03-08 | $2.90 | $3.11 | $2.88 | $3.03 | 54 000 |
| 2022-03-07 | $2.95 | $2.98 | $2.90 | $2.92 | 47 200 |
| 2022-03-04 | $3.01 | $3.08 | $2.90 | $2.96 | 79 500 |
| 2022-03-03 | $3.11 | $3.18 | $3.00 | $3.04 | 44 600 |
| 2022-03-02 | $3.14 | $3.15 | $3.03 | $3.10 | 33 800 |
| 2022-03-01 | $3.09 | $3.14 | $3.05 | $3.09 | 50 600 |
| 2022-02-28 | $3.07 | $3.10 | $2.99 | $3.05 | 35 400 |
| 2022-02-25 | $3.05 | $3.15 | $2.99 | $3.04 | 51 800 |
| 2022-02-24 | $2.85 | $3.12 | $2.85 | $3.08 | 124 200 |
| 2022-02-23 | $3.12 | $3.17 | $3.03 | $3.03 | 62 200 |
| 2022-02-22 | $3.11 | $3.19 | $3.05 | $3.12 | 90 200 |
| 2022-02-18 | $3.17 | $3.21 | $3.12 | $3.19 | 80 800 |
| 2022-02-17 | $3.24 | $3.25 | $3.12 | $3.17 | 59 500 |
| 2022-02-16 | $3.13 | $3.25 | $3.12 | $3.22 | 55 100 |
| 2022-02-15 | $3.02 | $3.18 | $3.02 | $3.12 | 72 700 |
| 2022-02-14 | $3.22 | $3.22 | $2.97 | $3.03 | 104 400 |
| 2022-02-11 | $3.27 | $3.27 | $3.10 | $3.20 | 58 300 |
| 2022-02-10 | $3.20 | $3.31 | $3.16 | $3.23 | 149 700 |
| 2022-02-09 | $3.20 | $3.29 | $3.19 | $3.23 | 36 800 |
| 2022-02-08 | $3.30 | $3.30 | $3.15 | $3.19 | 38 500 |
| 2022-02-07 | $3.15 | $3.29 | $3.12 | $3.28 | 81 900 |
| 2022-02-04 | $3.09 | $3.30 | $3.02 | $3.11 | 40 300 |
| 2022-02-03 | $3.10 | $3.11 | $3.03 | $3.05 | 48 800 |
| 2022-02-02 | $3.27 | $3.27 | $3.05 | $3.15 | 47 400 |
| 2022-02-01 | $3.15 | $3.27 | $3.10 | $3.22 | 58 400 |
| 2022-01-31 | $3.03 | $3.14 | $3.02 | $3.12 | 132 600 |
| 2022-01-28 | $2.91 | $3.07 | $2.87 | $3.07 | 85 700 |
| 2022-01-27 | $3.10 | $3.11 | $2.86 | $2.94 | 141 700 |
| 2022-01-26 | $3.18 | $3.20 | $3.00 | $3.06 | 129 600 |
| 2022-01-25 | $3.07 | $3.20 | $3.05 | $3.15 | 92 600 |
| 2022-01-24 | $3.01 | $3.20 | $2.75 | $3.15 | 323 000 |
| 2022-01-21 | $3.24 | $3.31 | $3.05 | $3.10 | 240 000 |
| 2022-01-20 | $3.31 | $3.41 | $3.20 | $3.24 | 85 000 |
| 2022-01-19 | $3.46 | $3.48 | $3.30 | $3.32 | 106 000 |
| 2022-01-18 | $3.51 | $3.53 | $3.32 | $3.39 | 107 200 |
| 2022-01-14 | $3.42 | $3.61 | $3.32 | $3.55 | 103 500 |
| 2022-01-13 | $3.55 | $3.65 | $3.43 | $3.43 | 64 300 |
About Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
